( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

Trump officials are capitalizing on lingering COVID resentment to undermine American vaccine policy.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

Move over, golden retriever boyfriends—this summer belongs to the 'black cat boyfriend.' We're breaking down the TikTok ...

This isn't scientific disagreement. It's either staggering incompetence or willful misrepresentation,” writes infectious disease physician Jake Scott.

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

Discover the potential consequences of mRNA vaccine development cuts on poultry health and infectious disease management in ...

The director of the National Institutes of Health, Jay Bhattacharya, explained why the federal government wound up $500 ...